-
ME-344/Bevacizumab Combo Shows Early Efficacy in mCRC
23 Apr 2024 17:43 GMT
… said Richard Ghalie, chief medical officer of MEI Pharma, … trial, investigators are evaluating ME-344 in combination with bevacizumab … analysis because of early treatment discontinuation before the first … mission of developing novel drug candidates to address …
-
Beyond Step Edits: Treatment Strategy After Bevacizumab in nAMD
23 Apr 2024 15:52 GMT
-
Samsung Bioepis Initiates Phase 3 Clinical Trial for Proposed Pembrolizumab Biosimilar
22 Apr 2024 16:51 GMT
… trials for SB27.”1
The phase 3 clinical trial … NSCLC). Investigators will randomize treatment 1:1 for SB27 … and United States-sourced drugs, according to an … etanercept, infliximab, adalimumab, trastuzumab, bevacizumab, ranibizumab, eculizumab, and aflibercept …
-
Nykode initiates Phase 2 trial in second line HPV16-positive cervical cancer
22 Apr 2024 12:14 GMT
… .16 trial for HPV16-positive cervical cancer addressing a high unmet medical … firstline treatment with pembrolizumab plus chemotherapy +/- bevacizumab.
The Phase 2 trial … quality and integrity in clinical trials in gynecologic malignancies. The GOG …
-
Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer
19 Apr 2024 05:00 GMT
… treatment with pembrolizumab, chemotherapy +/- bevacizumab into the trial … rejections, anti-drug antibody reactions and … clinical trials, and includes gynecologic oncologists, medical oncologists … pharmaceutical organizations and operate clinical trials …
-
Human medicines European public assessment report (EPAR): Alymsys, bevacizumab, Date of authorisation: 26/03/2021, Revision: 8, Status: Authorised
18 Apr 2024 16:54 GMT
… chemotherapy is indicated for treatment of adult patients with … breast cancer in whom treatment with other chemotherapy options … indicated for first line treatment of adult patients with … received prior therapy with bevacizumab or other VEGF inhibitors …
-
Progress in the Study of the Role and Mechanism of HTRA1 in Diseases Related to Vascular Abnormalities
18 Apr 2024 12:23 GMT
… ;- mice, thus suggesting that drugs with HTRA1 activity may be … cell death.105 Certain anticancer drugs, such as cisplatin and paclitaxel … -related Macular Degeneration Treatments Trials Research G. Ranibizumab and bevacizumab for treatment of neovascular …
-
Celltrion's Ramsima Products Garner 74% Market Share in EU5
23 Apr 2024 07:22 GMT
… , EU5).
According to the pharmaceutical market research firm IQVIA, as … world's largest pharmaceutical market, is also expected … including autoimmune disease and cancer drugs, are expanding.
As of … of last year, Vegzelma (bevacizumab) had a 9% share, …
-
Celltrion's Remsima attains 74% market share in 5 key European countries
23 Apr 2024 03:46 GMT
… -administering infliximab, a highly prescribed treatment for inflammatory bowel disease (IBD … cancer drugs. As of the fourth quarter of last year, Vegzelma (bevacizumab … .
According to Celltrion, in Europe, pharmaceutical supply is divided into tender …
-
Pearce IP BioBlast w/e 19 April 2024
22 Apr 2024 10:34 GMT
… with or without bevacizumab, as a treatment for patients with … Alvotech, Intas, and Shanghai Henlius Biotech.
12 APR 2024 | US … Nordisk’s Chronic Disease Medications Manufacturing Over 5 Years … of its acquisition of Cardior Pharmaceuticals for (up to) € …